FDA Rejects New Blood Thinner -- for Now
Links shared publicly online about this topic.
- 648total visits
FDA Rejects New Blood Thinner -- for Now
AstraZeneca's new blood thinner Brilinta worked better than Plavix in a head-to-head clinical trial -- but not in U.S. and Canadian patients. The FDA won't approve the drug without a new analysis of the study.
View full resource at webmd.com
Tags: Drug, Clinical Trial, FDA, Anti-Clotting Medication, Plavix, Brilinta, AstraZeneca
Most Recently Shared on December 18, 2010 at 4:27 am By:
FDA Rejects New Blood Thinner -- for Now - WebMD http://bit.ly/h5a0ov
Also Shared By:
Advertisement
WebMD_News
@WebMD_News
FDA Rejects New Blood Thinner -- for Now: AstraZeneca's new blood thinner Brilinta worked better than Plavix in ... http://bit.ly/gqT6A2
1 year ago...